L3VLUP
ProSign in

INSP · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

INSPJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • INSP
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterINSPJNJ
Q3 20208 holders, $638m30 holders, $26.2bn
Q4 202010 holders, $936m32 holders, $26.6bn
Q1 202110 holders, $790m31 holders, $25.3bn
Q2 202111 holders, $277m37 holders, $25.6bn
Q3 202111 holders, $486m40 holders, $24.1bn
Q4 202110 holders, $282m33 holders, $25.2bn
Q1 202214 holders, $1.3bn35 holders, $28.2bn
Q2 202213 holders, $790m33 holders, $26.9bn
Q3 202214 holders, $436m36 holders, $25.4bn
Q4 202215 holders, $740m35 holders, $27.6bn
Q1 202315 holders, $738m42 holders, $24.5bn
Q2 202318 holders, $1.2bn38 holders, $25.0bn
Q3 202313 holders, $1.1bn37 holders, $18.9bn
Q4 202310 holders, $1.6bn31 holders, $19.0bn
Q1 20248 holders, $2.0bn32 holders, $19.7bn
Q2 20247 holders, $666m35 holders, $20.4bn
Q3 202411 holders, $1.6bn28 holders, $22.3bn
Q4 202411 holders, $1.2bn37 holders, $20.4bn
Q1 202510 holders, $627m32 holders, $20.5bn
Q2 20257 holders, $649m31 holders, $18.4bn
Q3 20258 holders, $232m32 holders, $23.7bn
Q4 202510 holders, $554m29 holders, $27.8bn
Q1 20264 holders, $199m34 holders, $35.6bn
Q2 20263 holders, $45m33 holders, $39.1bn
INSP

Inspire Med Sys Inc

Holders
11
Reported value
$1.6bn
Buyers
7
Sellers
4

Breadth +3 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
28
Reported value
$22.3bn
Buyers
13
Sellers
16

Breadth -3 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2024

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only INSP (5)

Artisan Partners LP, Baillie Gifford & Co, PDT Partners LLC, Point72 Asset Management LP, Winton Group Ltd

Only JNJ (22)

Acadian Asset Management LLC, AllianceBernstein LP, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Dodge & Cox, Eisler Capital Management Ltd, GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Walleye Capital LLC, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →